Hi Dyeman,
While you are right, Spartensan an Endothelin A Receptor Blocker & ARB both block AT1-R they are slightly different drug classes. (Sparsentan a dual endothelin & angiotensin receptor blocker) there was also Atrasentan (an endothelin receptor blocker).
If we remember back to March 2021 & DMX-200 looking into Sparsentan & DMX-200 in vitro, they filed a new patent. I guess this will have greater importance to us now with what has recently (and positively) occurred for Travere, with the Vifor licencing deal.
Something that I remember some saw as insignificant & a few tiffs here at that time with the usually “it’s nothing” negativity.
Well it may be something very significant now in more ways than just DMX-200 as an adjunct to a therapy that has just moved into quite a substantial licencing deal with a Swiss International BP, but also the importance of both these inflammatory pathways in COVID-19 as well as kidney diseases (CKD/DKD).
AND that it looks like a newer class of drug (which is showing greater efficacy in Ph3 trials over ARB & is interchangeable with ARB & synergy with DMX-200, the potential for DMX-200 to enhance efficacy of these newer drugs as an adjunct therapy, by a different mechanism of targeting CCR2 inhibition.
I have screen shot the ANN. Be better than trying to post points, plus I need to get dinner on, hungry tribe!
Patent number is there & priority date of March 2021. I will take another look later tonight, but maybe you may get some time before I do Dyeman. I hope you are keeping well & life is treating you kindly. x
GLTAH.
- Forums
- ASX - By Stock
- DXB
- Ann: Phase 3 Study in FSGS Kidney Patients Commences
Ann: Phase 3 Study in FSGS Kidney Patients Commences, page-21
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
54.0¢ |
Change
0.030(5.88%) |
Mkt cap ! $297.1M |
Open | High | Low | Value | Volume |
51.0¢ | 54.0¢ | 49.5¢ | $2.265M | 4.358M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8490 | 53.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
54.0¢ | 204921 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8490 | 0.535 |
4 | 121489 | 0.530 |
4 | 51422 | 0.525 |
5 | 78594 | 0.520 |
3 | 40739 | 0.515 |
Price($) | Vol. | No. |
---|---|---|
0.540 | 204921 | 8 |
0.545 | 143296 | 3 |
0.550 | 214590 | 10 |
0.555 | 43798 | 2 |
0.560 | 39765 | 4 |
Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |